Every record from Janoshik · page 20
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041917 | L-Glutathione (reduced) | JEEP | JEEP-2510-S3920 | 2026-Q1 | 99.04 | 7.59 | 94.8 | Supplier-supplied | 0 | PASS |
| AX-2026-041907 | TB-500 | JEEP | JEEP-2510-R4058 | 2026-Q1 | 99.17 | 5.29 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041541 | 5-Amino-1MQ | QYB | QYB-2510-C6129 | 2026-Q1 | 99.27 | 3.46 | 107.0 | Supplier-supplied | 1 | FAIL |
| AX-2026-043058 | Semax | KP | KP-2509-J5482 | 2026-Q1 | 99.73 | 9.98 | 101.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042420 | Semaglutide | SWB | SWB-2602-W5529 | 2026-Q1 | 99.73 | 5.57 | 99.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041644 | Selank | QSC | QSC-2601-N8430 | 2026-Q1 | 99.39 | 6.80 | 106.8 | Supplier-supplied | 0 | PASS |
| AX-2026-043551 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | 2026-Q1 | 98.19 | 3.36 | 106.5 | Supplier-supplied | 1 | FAIL |
| AX-2026-043549 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | 2026-Q1 | 97.89 | 4.72 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-043438 | Melanotan II | WXT | WXT-2511-P5160 | 2026-Q1 | 99.80 | 4.51 | 105.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042837 | CJC-1295 with DAC | GGPeps | GGPE-2510-T1661 | 2026-Q1 | 98.06 | 5.71 | 93.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042752 | Liraglutide | GGPeps | GGPE-2510-V1048 | 2026-Q1 | 98.32 | 2.72 | — | Laboratory-retained | 0 | PASS |
| AX-2026-042610 | Semax | GGPeps | GGPE-2511-X8435 | 2026-Q1 | 98.36 | 7.80 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-041720 | BPC-157 | QSC | QSC-2510-J9685 | 2026-Q1 | 99.93 | 5.40 | 91.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043125 | Tirzepatide | SSA | SSA-2508-P6053 | 2026-Q1 | 97.92 | 4.94 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042427 | BPC-157 | SWB | SWB-2601-D5672 | 2026-Q1 | 99.87 | 3.76 | 103.8 | Supplier-supplied | 0 | PASS |
| AX-2026-041983 | Semaglutide | TFC | TFC-2602-H5189 | 2026-Q1 | 99.16 | 2.01 | 99.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041300 | TB-500 | WWB | WWB-2601-E2735 | 2026-Q1 | 99.93 | 4.01 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043210 | GHRP-6 | SGN | SGN-2510-P9566 | 2026-Q1 | 98.38 | 1.80 | 91.4 | Buyer-sourced | 1 | FAIL |
| AX-2026-042162 | Retatrutide | Homopeptide | HOMO-2601-J8878 | 2026-Q1 | 98.82 | 4.76 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-042145 | Leuprolide | Homopeptide | HOMO-2508-N8842 | 2026-Q1 | 99.45 | 4.99 | 105.9 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-041408 | PT-141 (Bremelanotide) | WWB | WWB-2509-A4716 | 2026-Q1 | 99.93 | 4.83 | 89.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043161 | Retatrutide | SSA | SSA-2601-T7702 | 2026-Q1 | 98.69 | 4.72 | 90.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041322 | ARA-290 | WWB | WWB-2511-S3009 | 2026-Q1 | 99.93 | 5.26 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043470 | BPC-157 | WXT | WXT-2508-E5954 | 2026-Q1 | 98.64 | 2.99 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042375 | Tirzepatide | SWB | SWB-2601-V4383 | 2026-Q1 | 99.27 | 4.19 | 98.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041871 | CJC-1295 with DAC | JEEP | JEEP-2601-V2811 | 2026-Q1 | 99.93 | 3.89 | 100.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041798 | BPC-157 | FGP | FGP-2512-A2448 | 2026-Q1 | 99.93 | 4.14 | 106.0 | Supplier-supplied | 0 | PASS |
| AX-2026-043486 | BPC-157 | WXT | WXT-2602-P5658 | 2026-Q1 | 98.24 | 2.01 | 104.4 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-042844 | CJC-1295 with DAC | GGPeps | GGPE-2510-T1661 | 2026-Q1 | 98.20 | 6.34 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-042515 | Semax | ERP | ERP-2512-G6974 | 2026-Q1 | 99.38 | 8.77 | 98.2 | Supplier-supplied | 0 | PASS |
| AX-2026-042448 | MGF | SWB | SWB-2601-E6319 | 2026-Q1 | 98.41 | 4.97 | 98.5 | Supplier-supplied | 0 | PASS |
| AX-2026-041995 | Semaglutide | TFC | TFC-2508-A5297 | 2026-Q1 | 98.50 | 4.21 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041674 | Ipamorelin | QSC | QSC-2602-W8804 | 2026-Q1 | 99.93 | 6.49 | 103.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043568 | Tirzepatide | BCH | BCH-2601-N7656 | 2026-Q1 | 97.51 | 4.06 | 99.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043265 | Selank | SGN | SGN-2508-Y1438 | 2026-Q1 | 98.41 | 5.23 | — | Buyer-sourced | 0 | FAIL |
| AX-2026-042834 | BPC-157 | GGPeps | GGPE-2512-N1746 | 2026-Q1 | 99.13 | 6.93 | 88.6 | Buyer-sourced | 2 | FAIL |
| AX-2026-042832 | BPC-157 | GGPeps | GGPE-2512-N1746 | 2026-Q1 | 99.65 | 7.00 | 102.7 | Supplier-supplied | 0 | PASS |
| AX-2026-043440 | Melanotan II | WXT | WXT-2511-P5160 | 2026-Q1 | 99.15 | 4.51 | — | Supplier-supplied | 3 | FAIL |
| AX-2026-042925 | Semaglutide | MKM | MKM-2508-R2718 | 2026-Q1 | 98.86 | 6.23 | 100.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042200 | Afamelanotide | Homopeptide | HOMO-2509-K9821 | 2026-Q1 | 99.12 | 4.65 | 95.4 | Supplier-supplied | 1 | MARGINAL |